Firms focused on drug discovery, genetic research, and life sciences.
Theme Performance
Equal-weight basket of constituents
1 Day
+0.90%
1 Week
+4.64%
1 Month
+4.11%
3 Months
+14.47%
Year to Date
+9.73%
Constituents
15 active symbols
| Ticker | Company | Market Cap | Price | 1D % | 1W % | 1M % | 3M % | YTD % |
|---|---|---|---|---|---|---|---|---|
| Amgen Inc | $202.420B | $374.4000 | -1.11% | +2.43% | +13.44% | +9.89% | +14.61% | |
| Gilead Sciences Inc | $187.492B | $151.9350 | -1.06% | -3.00% | +21.73% | +21.78% | +24.28% | |
| Vertex Pharmaceuticals Inc | $119.211B | $476.8050 | -0.22% | +1.74% | +6.15% | +8.12% | +3.79% | |
| Regeneron Pharmaceuticals Inc | $78.943B | $777.6500 | -1.23% | +0.44% | +6.62% | +11.08% | +0.78% | |
|
A
ARGX
|
argenx SE American Depositary Shares | $52.431B | $850.5900 | +0.23% | +1.52% | +4.65% | -8.86% | +0.87% |
| Alnylam Pharmaceuticals, Inc. | $45.008B | $340.5200 | +2.01% | +5.30% | -4.55% | -26.31% | -15.19% | |
| Biogen Inc. Common Stock | $28.189B | $191.7800 | -1.06% | +0.46% | +16.14% | +16.64% | +8.02% | |
|
B
BNTX
|
BioNTech SE American Depositary Share | $27.708B | $110.2000 | +2.29% | +0.95% | +4.60% | +7.55% | +14.20% |
| Incyte Genomics Inc | $20.246B | $101.0800 | -1.22% | +2.92% | -0.87% | -2.34% | +0.31% | |
| Illumina Inc | $18.348B | $117.0850 | -0.07% | +3.11% | -18.46% | -0.07% | -10.68% | |
| Moderna, Inc. Common Stock | $17.700B | $50.3300 | +6.65% | +22.69% | +15.58% | +100.73% | +61.05% | |
| Jazz Pharmaceuticals, Inc. | $9.995B | $171.7750 | +0.52% | +2.02% | +1.02% | -0.29% | -2.06% | |
| CRISPR Therapeutics AG | $5.245B | $53.6900 | +2.09% | +13.08% | +3.86% | -1.23% | +1.62% | |
| Beam Therapeutics Inc. Common Stock | $2.829B | $27.6950 | +1.16% | +7.27% | -9.96% | +26.61% | +2.73% | |
| Intellia Therapeutics, Inc | $1.510B | $12.8900 | +4.49% | +8.67% | +1.64% | +53.77% | +41.59% |
